UK markets open in 1 hour 23 minutes

NIKKEI 225
39,086.46
+469.36(+1.22%)
HANG SENG
18,880.36
-315.24(-1.64%)
CRUDE OIL
77.04
-0.53(-0.68%)
GOLD FUTURES
2,372.80
-20.10(-0.84%)
DOW
39,671.04
-201.95(-0.51%)
Bitcoin GBP
54,486.07
-421.52(-0.77%)

How to protect your finances during divorce

However you do it divorce will leave you poorer, and you will need to watch your finances carefully

OMER Jun 2024 3.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.7000

0.0000

(0.00%)

As of 10:58AM EDT. Market open.

Thomson Reuters StreetEvents
Q1 2024 Omeros Corp Earnings Call
Q1 2024 Omeros Corp Earnings Call
GuruFocus.com
Omeros Corp (OMER) Q1 2024 Earnings Call Transcript Highlights: Financial Shifts and Strategic ...
Amidst a significant net loss increase, Omeros Corp navigates through promising drug trials and strategic royalty milestones.
Business Wire
Omeros Corporation Reports First Quarter 2024 Financial Results
SEATTLE, May 15, 2024--Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders, today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2024, which include: